Estimating the range of potential epidemiological impact of pre-exposure prophylaxis: run-away success or run-away failure?

被引:15
作者
Cremin, Ide [1 ]
Hallett, Timothy B. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England
关键词
HIV prevention; mathematical modelling; pre-exposure prophylaxis; SUB-SAHARAN AFRICA; HIV-PREVENTION INTERVENTIONS; ANTIRETROVIRAL THERAPY; INTERIM GUIDANCE; SEX WORKERS; ADHERENCE; INFECTION; SCALE; COSTS; USERS;
D O I
10.1097/QAD.0000000000000591
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To investigate the influence of potential interactions between key aspects of a pre-exposure prophylaxis (PrEP) intervention on projections of epidemiological impact and cost-effectiveness. Methods: A mathematical model representing the HIV epidemic and intervention context in Nyanza province in Kenya was developed. We consider a scenario whereby a fixed annual budget is allocated to a PrEP intervention. A standard projection of impact is generated, assuming that the unit cost of PrEP, adherence to PrEP and the ability of the programme to direct PrEP to those at high risk, all stay constant. The influence of dynamic assumptions and possible interactions between PrEP intervention assumptions is then assessed in comparison. Results: The cumulative impact of a PrEP intervention could be increased approximately two-fold, relative to the standard projection, if positive interactions (between coverage and cost, coverage and adherence, prioritization and time) are assumed, whereas negative interactions between these factors could almost entirely negate the preventive benefit of the PrEP intervention. The corresponding estimates of cost per infection averted span a wide range from $2060 to $36 360. Conclusions: Multiple potentially interacting factors will determine the impact of PrEP. Model forecasts should reflect that uncertainty and programmes should focus on these factors and measure them, to maximize the impact of programmes. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:733 / 738
页数:6
相关论文
共 27 条
[1]   Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness [J].
Amico, K. Rivet .
CURRENT OPINION IN HIV AND AIDS, 2012, 7 (06) :542-548
[2]  
ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0
[3]  
[Anonymous], 2010, ICF MACR KEN DEM HLT
[4]  
[Anonymous], 2020, WEEXPAND PREP DEMONS
[5]  
[Anonymous], ONG PLANN PREP TRIAL
[6]  
[Anonymous], 2014, PREEXP PROPH PREV HI
[7]  
[Anonymous], FDA APPR 1 DRUG RED
[8]  
AVAHAN-The India AIDS Initiative, 2008, BUS HIV PREV SCAL
[9]   Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies [J].
Baernighausen, Till ;
Chaiyachati, Krisda ;
Chimbindi, Natsayi ;
Peoples, Ashleigh ;
Haberer, Jessica ;
Newell, Marie-Louise .
LANCET INFECTIOUS DISEASES, 2011, 11 (12) :942-951
[10]   Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don't We Know? [J].
Baeten, Jared M. ;
Grant, Robert .
CURRENT HIV/AIDS REPORTS, 2013, 10 (02) :142-151